Governing innovative science: Challenges facing the commercialization of plant-made pharmaceuticals

International Trade and Policies for Genetically Modified Products

Volumn , Issue , 2006, Pages 133-146

  Smyth, Stuart ^a   Khachatourians, George G ^a   Phillips, Peter W P ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890226434     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (34)

1. Animal and Plant Health Inspection Services (2003) Field Test Releases in the US Retrieved from the World Wide Web at: http://www.nbiap.vt. edu/cfdocs/fieldtests1.cfm
2. Bouquin, T., Thomsen, M., Nielsen, L.K., Green, T.H., Mundy, J. and Dziegiel, M.H. (2002) Human anti-Rhesus D IgG1 antibody produced in transgenic plants. Transgenic Research 11, 115-0122.
3. Cap Gemini, Ernst and Young (2002-02003) World Pharmaceutical Frontiers, p. 77.
4. Chikwamba, R.J., Cunnick, D., Hathaway, J., McMurray, H., Mason, H.S. and Wang, K. (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Research 11, 479-0493.
5. Daniell, H., Streatfield, S.J. and Wycoff, K. (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and ediblevaccines in plants. Trends in Plant Science 6, 219-0226.
6. Degray G., Rajasekaran, K., Smith, F., Sanford, J. and Daniell, H. (2001) Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiology 127, 852-0862.
7. Fahrner, R.L., Knudsen, H.L., Basey, C.D., Galan, W., Feuerhelm, D., Vanderlaan, M. and Blank, G.S. (2001) Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography process. Biotechnology and Genetic Engineering Reviews 18, 301-0327.
8. Faye, L., Lerouge, P. and Gomord, V. (2003). Production de molecules pharmaceutiques. Annales de Pharmacologie 61, 109-0118.
9. Gao, Y., Ma, Y., Li, M., Cheng, T., Li, S.W., Zhang, J. and Xia, N.S. (2003) The oral vaccination of HBV by cherry tomatillo transformed with HBsAg. Chinese Journal of Virology 19, 31-035.
10. Gomez, N., Wigdorovitz, A., Castanon, S., Gil, F., Ordas, R., Borca, M.V. and Escribano, J.M. (2000) Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Archives for Virology 145, 1725-01732.
11. Hileman, B. (2002) Drugs from plants stir debate. Chemical Engineering News 80, 22-025.
12. James, C. (2003) Global Status of Commercialized Transgenic Crops: 2002. ISAAA Brief No. 27. Retrieved from the World Wide Web at: www.isaaa.org
13. Khachatourians, G.G., McHughen, A., Nip, W.K., Scorza, R. and Hui, Y.H. (eds) (2002) Transgenic Plants and Crops. Marcel Dekker Inc., New York.
14. Kong, Q., Richter, L., Yang, Y.F., Arntzen, C.J., Mason, H.S. and Thanavala, Y. (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proceedings of the National Academy of Sciences of the USA 98, 11539-011544.
15. Ma, J.K-C., Drake, P.M.W. and Christou, P. (2003) The production of recombinant pharmaceutical proteins in plants. Nature Genetics 4, 794-0805.
16. Marquet, B.E., Bouche, F.B., Steinmetz, A. and Muller, C.P. (2003) Neutralizing immunogenicity of transgenic carrot (Daucus carota L.) derived measles virus hemagglutinin. Plant Molecular Biology 51, 459-0469.
17. Mason, H.S., Ball, J.M., Shi, J., Jiang, X., Estes, M.K. and Arntzen, C.J. (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proceedings of the National Academy of Sciences of the USA 93, 5335-05340.
18. McCloskey, R. (2002) Presentation to the Pew Initiative on Food and Biotechnology Conferance. Retrieved from the World Wide Web at: http://pewagbiotech.org/events/0717/ ConferenceReport.pdf
19. Ohya, K., Matsumura, T., Itchoda, N., Ohashi, K., Onuma, M., Sugimoto, C. and Vasil, I.K. (2003) Protective effect of orally administered human interferon (HuIFN)-alpha against systemic Listeria monocytogenes infection and a practical advantage of HuIFN-alpha derived from transgenic potato plant. Plant Biotechnology 2002 and Beyond. Proceedings of the 10th IAPTC and B Congress, Orlando, Florida. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 389-0391.
20. Pew Initiative on Food and Biotechnology (2002) Pharming the field: a look at the benefits and risks of bioengineering plants to produce pharmaceuticals. Retrieved from the World Wide Web at: http://pewagbiotech.org/events/ 0717/ConferenceReport.pdf
21. Potera, C. (2003) TMV uses could convert tobacco into a weed for health. American Society for Microbiology News 69, 376.
22. Quist, D. and Chapela, I. (2001) Transgenic DNA introgressed into traditional maize landraces in Oaxaca, Mexico. Nature 414, 541-0543.
23. Richter, L.J., Thanavala, Y., Arntzen C.J. and Mason, H.S. (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnology 18, 1167-01171.
24. Rocci, R. and Gobbo, M. (2002) Peptide science in the years to come. Chimica Oggi 20, 26-029.
25. Sandhu, J.S., Krasnyanski, S.F., Domier, L.L., Korban, S., Osadjan, M.D. and Buetow, D.E. (2000) Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Research 9, 127-0135.
26. Smyth, S., Khachatourians, G.G. and Phillips, P.W.B. (2002) Liabilities and economics of transgenic crops. Nature Biotechnology 20, 537-541.
27. Snow, A., Pilson, D., Rieseberg, L., Paulsen, M., Pleskac, N., Reagon, M., Wolf, D. and Selbo, S. (2003) A Bt transgene reduces herbivory and enhances fecundity in wild sunflowers. Ecological Applications 13, 279-0286.
28. Sojikul, P., Buehner, N. and Mason, H.S. (2003) A plant signal peptide-0hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proceedings of the National Academy of Sciences of the USA 100, 2209-02214.
29. Tacket, C.O., Mason, H.S., Losonsky, G., Estes, M.M., Levine, M.M. and Arntzen, C.J. (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. Journal of Infectious Diseases 182, 302-0305.
30. Tacket, C.O., Mason, H.S., Losonsky, G., Clements, J.D., Levine, M.M. and Arntzen, C.J. (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Medicine 4, 607-0609.
31. Verlander, M. (2002) Large scale manufacturing methods for peptides -0 a status report. Chimica Oggi 20, 62-066.
32. Washington Post (2003) Firm fined for spread of altered corn genes. Thursday, April 24, E4.
33. Yu, J. and Langridge, W.H.R. (2001) A plant-based multicomponent vaccine protects mice from enteric diseases. Nature Biotechnology 19, 548-0552.
34. Yusibov, V., Hooper, D.C. Spitsin, S.V., Fleysh, N., Kean, R.B., Mikheeva, T., Deka, D., Karasev, A., Cox, S., Randall, J. and Koprowsk, H. (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20, 3155-03164.